Diagnostic Approach for Patients with Visible Blood in Stool

Rationale for Direct Colonoscopy

The American Gastroenterological Association recommends direct colonoscopy for patients presenting with fresh blood in stool plus dark stool color, without prior Fecal Immunochemical Testing (FIT), as visible blood in stool represents an alarm symptom that warrants immediate evaluation with colonoscopy rather than preliminary stool testing 1, 2
When patients present with overt bleeding symptoms, the positive predictive value for significant neoplasia is high, making colonoscopy the optimal first-line test 2
Colonoscopy is the one structural examination that both directly evaluates the entire colorectal mucosa and affords the opportunity to simultaneously remove significant neoplasia 2

The American Cancer Society recommends FIT as a screening tool for average-risk, asymptomatic individuals, but it has not been validated as a diagnostic test in symptomatic patients with visible blood in stool 1, 3
Using FIT in patients with overt bleeding may delay necessary diagnostic evaluation and potentially miss significant lesions 2

The American Cancer Society recommends FIT as a screening tool for average-risk, asymptomatic individuals aged 50 years and older 1, 3
When FIT is used for screening and returns positive, colonoscopy is the recommended follow-up test 1, 2

Delaying colonoscopy to perform FIT in patients with visible blood may postpone diagnosis of significant colorectal pathology 2

A complete blood count to assess for anemia, iron studies if iron deficiency anemia is suspected, and coagulation studies if bleeding disorder is suspected should be performed concurrently with, not prior to, scheduling colonoscopy in patients with visible blood in stool 2